Suppr超能文献

中药和天然产物靶向调节肠道微生物群治疗肝脏疾病。

Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy.

机构信息

Anhui Institute of Pediatric Research, Anhui Provincial Children's Hospital, Hefei, Anhui, China.

Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, China.

出版信息

Front Immunol. 2023 Feb 2;14:1086078. doi: 10.3389/fimmu.2023.1086078. eCollection 2023.

Abstract

The gut microbiota not only constitutes intestinal microenvironment homeostasis and human health but also exerts indispensable roles in the occurrence and progression of multiple liver diseases, including alcohol-related liver disease, nonalcoholic fatty liver disease, autoimmune liver disease and liver cancer. Given the therapeutic status of these diseases, their prevention and early therapy are crucial, and the detailed mechanism of gut microbiota in liver disease urgently needs to be explored. Meanwhile, multiple studies have shown that various traditional Chinese medicines, such as Si Miao Formula, Jiangzhi Granules, Liushen Capsules, Chaihu-Shugan Power, Cassiae Semen and Gynostemma, as well as some natural products, including Costunolide, Coprinus comatus polysaccharide, Antarctic krill oil, Oridonin and Berberine, can repair liver injury, improve fatty liver, regulate liver immunity, and even inhibit liver cancer through multiple targets, links, and pathways. Intriguingly, the aforementioned effects demonstrated by these traditional Chinese medicines and natural products have been shown to be closely related to the gut microbiota, directly driving the strategy of traditional Chinese medicines and natural products to regulate the gut microbiota as one of the breakthroughs in the treatment of liver diseases. Based on this, this review comprehensively summarizes and discusses the characteristics, functions and potential mechanisms of these medicines targeting gut microbiota during liver disease treatment. Research on the potential effects on gut microbiota and the regulatory mechanisms of traditional Chinese medicine and natural products provides novel insights and significant references for developing liver disease treatment strategies. In parallel, such explorations will enhance the comprehension of traditional Chinese medicine and natural products modulating gut microbiota during disease treatment, thus facilitating their clinical investigation and application.

摘要

肠道微生物群不仅构成肠道微环境的稳态和人体健康,而且在多种肝脏疾病(包括酒精性肝病、非酒精性脂肪性肝病、自身免疫性肝病和肝癌)的发生和进展中发挥不可或缺的作用。鉴于这些疾病的治疗状况,预防和早期治疗至关重要,肠道微生物群在肝病中的详细机制亟待探索。同时,多项研究表明,多种中药,如四妙方、降脂颗粒、六神胶囊、柴胡疏肝散、决明子和绞股蓝,以及一些天然产物,如木香烃内酯、鸡腿菇多糖、南极磷虾油、冬凌草甲素和黄连素,可通过多种靶点、环节和途径修复肝损伤、改善脂肪肝、调节肝免疫,甚至抑制肝癌。有趣的是,这些中药和天然产物所表现出的上述作用与肠道微生物群密切相关,直接推动了中药和天然产物调节肠道微生物群的策略成为治疗肝病的突破之一。基于此,本综述全面总结和讨论了这些针对肝病治疗中肠道微生物群的药物的特征、功能和潜在机制。对中药和天然产物对肠道微生物群的潜在作用及其调节机制的研究为开发肝病治疗策略提供了新的见解和重要参考。同时,这种探索将增强对中药和天然产物在疾病治疗过程中调节肠道微生物群的理解,从而促进它们的临床研究和应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372e/9933143/07ccdf510a43/fimmu-14-1086078-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验